| 439 |
Activation of the AhR leading to metastatic breast cancer |
Louise Benoit |
BY-SA |
18: Activation, AhR
|
1982: metastatic breast cancer
|
Under Review |
1.105 |
| 438 |
reactive oxygen species generation leading to increased cardiovascular morbidity and mortality |
Yu Yang |
All rights reserved |
None
|
None
|
|
|
| 437 |
Inhibition of mitochondrial electron transport chain (ETC) complexes leading to kidney toxicity |
Baki Sadi |
BY-SA |
105: Inhibition, Mitochondrial Electron Transport Chain Complexes
|
814: Occurrence, Kidney toxicity
|
Under Development |
1.99 |
| 436 |
Inhibition of RALDH2 causes reduced all-trans retinoic acid levels, leading to transposition of the great arteries |
Gina Mennen |
BY-SA |
1880: Decreased, ALDH1A (RALDH) enzyme activity
|
1970: transposition of the great arteries
|
|
|
| 435 |
Deposition of ionising energy leads to population decline via pollen abnormal |
Li Xie |
BY-SA |
1686: Deposition of Energy
|
2 AOs
|
|
|
| 434 |
CYP26 inhibition leading to disturbed dorsal lateral hinge point bending which causes neural tube closure defects |
Job Berkhout |
All rights reserved |
None
|
None
|
|
|
| 433 |
hERG channel blockade leading to sudden cardiac death |
Egemen Bilgin |
BY-SA |
2099: hERG channel blockade
|
1964: Sudden cardiac death
|
|
|
| 432 |
Deposition of Energy by Ionizing Radiation leading to Acute Myeloid Leukemia |
Dag Anders Brede |
All rights reserved |
1686: Deposition of Energy
|
1955: Acute Myeloid Leukemia
|
|
|
| 431 |
Increased tumor necrosis factor (TNF) leading to increased risk of gestational diabetes mellitus (GDM) |
Qi Wang |
BY-SA |
1950: Increase, TNF
|
1953: Gestational diabetes mellitus
|
|
|
| 430 |
Binding of SARS-CoV-2 to ACE2 leads to viral infection proliferation |
Sally Mayasich |
All rights reserved |
1739: Binding to ACE2
|
1939: Viral infection and host-to-host transmission, proliferated
|
Under Development |
1.96 |
| 429 |
A cholesterol/glucose dysmetabolism initiated Tau-driven AOP toward memory loss (AO) in sporadic Alzheimer's Disease with plausible MIE's plug-ins for environmental neurotoxicants |
Erwin L Roggen |
BY-SA |
None
|
1941: Memory Loss
|
|
|
| 428 |
Binding of S-protein to ACE2 in enterocytes induces ACE2 dysregulation leading to gut dysbiosis |
Laure-Alix Clerbaux |
BY-SA |
1739: Binding to ACE2
|
None
|
Under Development |
1.96 |
| 427 |
ACE2 downregulation following SARS-CoV-2 infection triggers dysregulation of RAAS and can lead to heart failure. |
Evangelos-Panagiotis Daskalopoulos |
BY-SA |
1739: Binding to ACE2
|
1535: Heart failure
|
|
|
| 426 |
SARS-CoV-2 spike protein binding to ACE2 receptors expressed on pericytes leads to endothelial cell dysfunction, microvascular injury and myocardial infarction. |
Evangelos-Panagiotis Daskalopoulos |
BY-SA |
1739: Binding to ACE2
|
1934: Myocardial Infarction
|
|
|
| 425 |
Oxidative Stress Leading to Decreased Lung Function via Decreased FOXJ1 |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|
| 424 |
Oxidative stress Leading to Decreased Lung Function via CFTR dysfunction |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|
| 423 |
Toxicological mechanisms of hepatocyte apoptosis through the PARP1 dependent cell death pathway |
Fei Li |
BY-SA |
2 MIEs
|
1817: Apoptotic cell death
|
|
|
| 422 |
Binding of SARS-CoV-2 to ACE2 in enterocytes leads to intestinal barrier disruption |
Laure-Alix Clerbaux |
BY-SA |
1739: Binding to ACE2
|
None
|
Under Development |
1.96 |
| 421 |
PPARG activation leading to intrahepatic cholestasis |
Yuan Jin |
All rights reserved |
None
|
None
|
|
|
| 420 |
Aryl hydrocarbon receptor activation leading to lung cancer through sustained NRF2 toxicity pathway |
Dianke Yu |
All rights reserved |
18: Activation, AhR
|
None
|
|
|
| 419 |
Aryl hydrocarbon receptor activation leading to impaired lung function through P53 toxicity pathway |
Dianke Yu |
All rights reserved |
None
|
1250: Decrease, Lung function
|
|
|
| 418 |
Aryl hydrocarbon receptor activation leading to impaired lung function through AHR-ARNT toxicity pathway |
Dianke Yu |
All rights reserved |
None
|
None
|
|
|
| 417 |
Aryl hydrocarbon receptor activation leading to lung cancer through AHR-ARNT toxicity pathway |
Dianke Yu |
All rights reserved |
18: Activation, AhR
|
1670: Lung cancer
|
|
|
| 416 |
Aryl hydrocarbon receptor activation leading to lung cancer through IL-6 toxicity pathway |
Dianke Yu |
All rights reserved |
18: Activation, AhR
|
1670: Lung cancer
|
|
|
| 415 |
Aryl hydrocarbon receptor activation leading to lung fibrosis through IL-6 toxicity pathway |
Dianke Yu |
All rights reserved |
18: Activation, AhR
|
1276: Lung fibrosis
|
|
|